FMP
Dec 03, 2025
Thor Industries, Inc. (NYSE:THO) is a prominent player in the recreational vehicle (RV) industry, known for manufacturing a wide range of RVs. The company operates in the Zacks Building Products - Mobile Homes and RV Builders industry, competing with other major players in the sector. Thor's recent financial performance has been noteworthy, reflecting its strong market position and operational efficiency.
On December 3, 2025, Thor Industries reported earnings per share (EPS) of $0.40, significantly surpassing the estimated loss of $0.11. This impressive performance highlights the company's ability to exceed market expectations, as the EPS marked a 472.73% positive surprise compared to analyst estimates. The EPS also showed a substantial increase from $0.26 a year ago, indicating strong growth.
Thor Industries achieved a revenue of approximately $2.39 billion for the quarter ended October 2025, exceeding the estimated $1.98 billion. This revenue figure represents an 11.5% increase compared to the same period last year, showcasing the company's robust sales performance. The revenue also surpassed the Zacks Consensus Estimate of $2.12 billion by 12.9%, further emphasizing Thor's strong market presence.
The company's gross profit for the quarter grew by 14% year over year to $321 million, with the gross margin expanding by 30 basis points to 13.4%. Additionally, the quarterly adjusted EBITDA rose by 21.5% year over year to $131 million. These positive financial metrics underscore Thor Industries' operational efficiency and ability to generate strong profits.
Despite the impressive financial results, Thor Industries reported an operating cash outflow of $44.9 million for the quarter. However, the company concluded the period with $509.9 million in cash and equivalents, indicating a strong liquidity position. Thor's low debt-to-equity ratio of nearly 0.00066 further highlights its financial stability, making it an attractive option for investors.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) leads the market's top gainers with a remarkable 351.89% increase in its stock...
Capricor Therapeutics, listed on the NASDAQ as CAPR, is a biotechnology company focused on developing cell therapies for...